|
C7ORF11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.64950000009534E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.93239999999062E-06 |
| Normal-vs-Stage2 |
5.047200E-01 |
| Normal-vs-Stage3 |
2.50310000005083E-06 |
| Normal-vs-Stage4 |
1.43320000312031E-09 |
| Stage1-vs-Stage2 |
6.112200E-02 |
| Stage1-vs-Stage3 |
3.458800E-01 |
| Stage1-vs-Stage4 |
4.159900E-03 |
| Stage2-vs-Stage3 |
2.951600E-02 |
| Stage2-vs-Stage4 |
1.198220E-03 |
| Stage3-vs-Stage4 |
5.101800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.9437000004815E-07 |
| Normal-vs-AfricanAmerican |
1.351280E-04 |
| Normal-vs-Asian |
4.27880000000158E-05 |
| Caucasian-vs-AfricanAmerican |
7.158600E-01 |
| Caucasian-vs-Asian |
9.816200E-01 |
| AfricanAmerican-vs-Asian |
7.118400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.30360000000418E-06 |
| Normal-vs-Female |
2.04680000004398E-06 |
| Male-vs-Female |
6.110000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.65959999987831E-07 |
| Normal-vs-Age(41-60Yrs) |
1.07299999996258E-06 |
| Normal-vs-Age(61-80Yrs) |
1.277170E-03 |
| Normal-vs-Age(81-100Yrs) |
5.581500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.021200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.095200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.298600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.944800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.236800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.885800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.172270E-02 |
| Classical-VS-Follicular |
3.79279999995763E-06 |
| Classical-VS-Other |
1.260400E-01 |
| Classical-VS-Normal |
4.26210000625815E-09 |
| Tall-VS-Follicular |
3.03610000473853E-08 |
| Tall-VS-Other |
3.095800E-03 |
| Tall-VS-Normal |
2.23459994952435E-09 |
| Follicular-VS-Other |
3.159000E-01 |
| Follicular-VS-Normal |
9.765200E-01 |
| Other-VS-Normal |
3.643800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.952400E-04 |
| Normal-vs-N1 |
4.20700000000052E-05 |
| N0-vs-N1 |
1.584400E-01 |
|
|
